Abstract
Treatment of SLE: bridging the gap from clinical trials to the clinic - a meeting report
Highlights
Systemic lupus erythematosus (SLE) is a complicated disease that frustrates many clinicians with its wide variety of presentations, signs, and symptoms
Treatment of systemic lupus erythematosus (SLE): Bridging the Gap from Clinical Trials to Practice. These abstracts are available online at http://arthritis-research.com/supplements/15/S2. These abstracts originated from the “Treatment of SLE: Bridging the Gap from Clinical Trials to Practice” Symposium held during the Annual Congress of the American College of Rheumatology on 11 November 2012
The symposium and subsequent publication of this supplement were funded by an unrestricted educational grant from Human Genome Sciences
Summary
Systemic lupus erythematosus (SLE) is a complicated disease that frustrates many clinicians with its wide variety of presentations, signs, and symptoms. A1 Treatment of SLE: bridging the gap from clinical trials to the clinic – a meeting report Leonard H Calabrese* Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Department of Rheumatic and Immunologic Diseases, Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, USA E-mail: CALABRL@ccf.org Arthritis Research & Therapy 2013, 15(Suppl 2):A1
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
